Early Serum Infliximab Levels in Severe Ulcerative Colitis.

Clinical trial NCT01971814 · COMPLETED

Trial details

NCT number: NCT01971814
Sponsor: University of California, San Francisco
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Ulcerative Colitis (UC)Inflammatory Bowel Disease

Start date: 2013-11-01
Primary completion: 2015-01-01
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.